3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is increasingly attracting researcher attention due to limited evidence suggesting different biological characteristics. Present research suggest that 3-HPC may possess distinct responses on the central nervous system, potentially influencing to some of the unexpected sympt